Investigating how organophosphorus pesticides affect brain development

Comparative mechanistic study of developmental neurotoxicity of organophosphorus pesticides

NIH-funded research Swarthmore College · NIH-10653649

This study is looking into how long-term exposure to certain insecticides, called organophosphorus pesticides, might harm brain development and behavior in babies and young children, so we can better understand the risks and help keep families safe.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionSwarthmore College NIH-funded
Lab location1 site (Swarthmore, United States)
Project IDNIH-10653649 on NIH RePORTER

What this research studies

This research focuses on understanding the potential neurological damage caused by organophosphorus pesticides (OPs), which are widely used insecticides. It aims to explore how chronic exposure to these chemicals, even at legal levels, may lead to long-term behavioral disorders and brain development issues in humans, particularly during prenatal and infant stages. The study employs high-throughput screening methods using non-mammalian organisms to efficiently assess the toxicity mechanisms of individual OPs and their mixtures. By identifying the pathways affected by these pesticides, the research seeks to clarify the risks associated with their use and inform safety regulations.

Who could benefit from this research

Good fit: Ideal candidates for this research are pregnant women and infants who may be exposed to organophosphorus pesticides.

Not a fit: Patients who are not pregnant or infants, and those not exposed to organophosphorus pesticides, may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved safety regulations for pesticide use, ultimately protecting vulnerable populations from neurological harm.

How similar studies have performed: Previous research has indicated potential risks associated with organophosphorus pesticide exposure, but this approach of using high-throughput screening in non-mammalian models is relatively novel.

Where this research is happening

Swarthmore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Behavior Disordersbehavioral disorder
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.